The Central Drug Laboratory in Kasauli released the first few batches of Zydus Cadila’s Covid-19 vaccine ZyCoV-D on Friday, which are expected to be included in the government’s immunisation campaign later this month.
“Four batches of the new DNA vaccine by Zydus Cadila have been released from the laboratory for commercial use,” a senior official said, adding that the four batches would contain about 150,000 doses in total.
The three-dose, needle-free ZyCoV-D vaccine, made by Ahmedabad-based Zydus Cadila, is India’s first Covid-19 vaccine licenced for children aged 12 to 18.
The Centre is presently negotiating the pricing of the vaccination with Zydus Cadila. People in the know informed ET that experts are looking at a price range of $250-300. The government has been purchasing Covishield from AstraZeneca and Covaxin from Bharat Biotech for 157.50 and 225.75 per dosage, respectively.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…